Table 1.
Emerging therapies targeting lactate metabolism in cancer cells.
Compounds | Mechanisms | T cell functional effects | Impacts on tumor | Ref |
---|---|---|---|---|
Lithium |
Block lysosomal acidification Rescue lysosomal diacylglycerol–PKCθ signaling Localize MCT1 to the mitochondrial membrane |
Attenuate lactate-induced CD8+ T cell immunosuppression Improve T cell energy utilization |
Improve tumor immunosuppression | [57] |
Dichloroacetate |
Inhibit macrophage ARG1 expression Inhibit IL-23/IL-17 pathway Reduce lactic acid production |
Enhance T cell response | Promote anti-tumor immunotherapy | [58, 59] |
Dimethyl fumarate | Inhibit GAPDH | Enhance TIL anti-tumor response | Inhibit tumor growth | [60] |
Switch-2 |
Bind to IL-2 receptor subunit IL-2Rα Trigger STAT5 activation |
Activate CD8+ T cells | Enhance anti-tumor response | [61] |
Gd/CeO2 |
Oxidize lactic acid; generate -OH Induce mitochondrial damage |
Activate CD8+ T cells | Enhance anti-tumor immunity | [62] |
APAP-P-NO |
Produce large quantities of nitrite S-nitrosylation impair GAPDH activity |
Reduce Treg cells Promote CD8+ T cells infiltration |
Reverse immunosuppression TME | [63] |
HMONs@HCPT-BSA-PEI-CDM-PEG@siMCT-4 | Inhibit lactate efflux | Restore T cell activity | Inhibit tumor growth and metastasis | [64] |
Sodium lactate | Inhibit histone deacetylase in CD8+ T cells | Increase TCF-1 expression | Promote cancer immunotherapy | [65] |